The US Food and Drug Administration (USFDA) h as removed the Import Alert 66-40 on Divis Laboratories’ Unit-II at Visakhapatnam. The regulator had earlier imposed the Import Alert on the company’s Unit-II at Visakhapatnam.
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1850.65 |
| Dr. Reddys Lab | 1273.85 |
| Cipla | 1330.95 |
| Zydus Lifesciences | 932.75 |
| Lupin | 2239.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: